Treatment-induced menopause linked to lasting vaginal changes
Vaginal health worsened within three months of menopause onset in women receiving breast cancer therapy; bacterial shifts persisted for up to 33 months.
Our read
Populations- Studied:
- Preprint: cohort study of 60 premenopausal women with breast cancer, up to 33 months (Multicenter)
- What changed:
- Vaginal bacteria lost Lactobacillus dominance after menopause onset, with shifts persisting for up to 33 months
- The catch:
- Concurrent breast cancer treatment makes treatment effects difficult to separate from menopause effects
Editor of record: Boris Djordjevic · AgingResearch.News
Sixty women who had not yet reached menopause and had stage I–IIIC breast cancer took part in a multicenter prospective longitudinal study. Researchers assessed them at four visits, from before treatment through treatment-induced menopause, using gynecologic examinations, vaginal bacterial analyses, estrogen measurements and questionnaires.
Within three months of menopause onset, the health of the vagina and surrounding genital tissue worsened, and sexual dysfunction became more common, particularly among women receiving endocrine therapy, which acts on hormones. Vaginal bacterial communities shifted away from dominance by Lactobacillus bacteria and became more diverse. These shifts were more pronounced with endocrine therapy and persisted for up to 33 months, including among women whose estrogen later returned to premenopausal levels. The authors said this suggested limited ability of the vaginal bacterial community to recover.
Why it matters
Menopause-related genital and sexual problems are a concern in breast cancer survivorship. The authors called for early intervention and exploration of ways to modify vaginal bacteria.
Caveats
Breast cancer treatment and menopause occurred together, making their separate contributions difficult to distinguish. These findings may not apply to natural menopause; the preprint has not been peer-reviewed.
- Breast cancer therapy
- Endocrine therapy
- Microbiome composition
- Sex hormone signaling (estrogen, androgen)
- Breast cancer
- Humans
The paper
University Hospitals Leuven/KU Leuven; University of Antwerp
Research Square, Nov 18, 2026, Open access, Preprint, not yet peer-reviewed
Comments
Be the first to comment.